Mechanisms of inhibition of dehydroepiandrosterone upon corticosterone release from rat zona fasciculata-reticularis cells

Journal of Cellular Biochemistry

Volumn 104, Issue 2, 2008, Pages 359-368

  Chang, Ling Ling ^a   Wun, Wan Song Alfred ^b   Wang, Paulus S ^c,d  

^a CHINESE CULTURE UNIVERSITY   (Taiwan)

^b Obstetrical and Gynecological Associates   (United States)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

DHEA; ERK; SF 1; StAR; Zona fasiculata reticularis cells

Indexed keywords

CHOLESTEROL; CORTICOSTERONE; CORTICOTROPIN; CYCLIC AMP; CYTOCHROME P450; FORSKOLIN; MITOGEN ACTIVATED PROTEIN KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PRASTERONE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; STEROIDOGENIC FACTOR 1; UO 126;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; FEMALE; IMMUNOPRECIPITATION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; STEROIDOGENESIS; WESTERN BLOTTING; ZONA FASCICULATA;

ANIMALS; CELLS, CULTURED; CORTICOSTERONE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DEHYDROEPIANDROSTERONE; GENE EXPRESSION REGULATION; MAP KINASE SIGNALING SYSTEM; PHOSPHOPROTEINS; PHOSPHORYLATION; RATS; STEROIDOGENIC FACTOR 1; STEROIDS; ZONA FASCICULATA; ZONA RETICULARIS;

RATTUS;

EID: 43449135618     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21627     Document Type: Article

References (49)

1. Aragno M, Tamagno E, Boccuzzi G, Brignardello E, Chiarpotto E, Pizzini A, Danni O. 1993. Dehydroepiandrosterone pretreatment protects rats against the prooxidant and necrogenic effects of carbon tetrachloride. Biochem Pharmacol 46:1689-1694.
2. Aragno M, Brignardello E, Tamagno E, Gatto V, Danni O, Boccuzzi G. 1997. Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats. J Endocrinol 155:233-240.
3. Aragno M, Tamagno E, Gatto V, Brignardello E, Parola S, Danni O, Boccuzzi G. 1999. Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress. Free Radic Biol Med 26:1467-1474.
4. Bastianetto S, Ramassamy C, Poirier J, Quirion R. 1999. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res 66:35-41.
5. Berdanier CD, Parente JA, Jr., McIntosh MK. 1993. Is DHEA an antiobesity agent? FASEB J 7:414-419.
6. Boccuzzi G, Aragno M, Seccia M, Brignardello E, Tamagno E, Albano E, Danni O, Bellomo G. 1997. Protective effect of dehydroepiandrosterone against copper-induced lipid peroxidation in the rat. Free Radic Biol Med 22:1289-1294.
7. Bornfeldt KE, Krebs EG. 1999. Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. Cell Signal 11:465-477.
8. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
9. Brignardello E, Beltramo E, Molinatti PA, Aragno M, Gatto V, Tamagno E, Danni O, Porta M, Boccuzzi G. 1998. Dehydroepiandrosterone protects bovine retinal capillary pericytes against glucose toxicity. J Endocrinol 158: 21-26.
10. Cameron MR, Foster JS, Bukovsky A, Wimalasena J. 1996. Activation of mitogen-activated protein kinases in gonadotropins and cyclic adenosine 5′-monophosphates in porcine granulose cells. Biol Reprod 55:111-119.
11. Chang LL, Tseng YC, Lin YL, Wun WSA, Wang PS. 2002. Effects of S-petasin on corticosterone release in rats. Chin J Physiol 45:137-142.
12. Chang LL, Wun WSA, Ho LT, Wang PS. 2003. Effects of dehydroepiandrosterone on corticosterone release in rat zona fasciculata-reticularis cells. Naunyn Schmiedebergs Arch Pharmacol 368:487-495.
13. Chiao YC, Cho WL, Wang PS. 2002. Inhibition of testosterone production by propylthiouracil in rat Leydig cells. Biol Reprod 67:416-422.
14. Clark BJ, Wells J, King SR, Stocco DM. 1994. The purification, cloning and expression of a novel LH-induced mitochondrial protein in MA-10 mouse Leydig tumor cells: Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem 269:28314-28322.
15. Cleary M. 1990. Role of DHEA in obesity. In: Kalimi M, Regelson W, editors. The biological role of dehydroepiandrosterone. Berlin: Walter de Gruyter. pp 356-361.
16. Clegg CH, Abrahamsen MS, Degen JL, Morris DR, Mcknight GS. 1992. Cyclic AMP-dependent protein kinase controls base gene activity and steroidogenesis in Y1 adrenal tumor cells. Biochemistry 31:3720-3726.
17. Coleman DL. 1989. Therapeutic effects of DHEA and its metabolites in diabetes-obesity mutants. In: Lardy H, Stratman F, editors. Hornones, thermogenesis, and obesity. New York: Elsevier. pp 377-384.
18. Das S, Maizels ET, DeManno D, St Clair E, Adam SA, Hunzicker-Dunn M. 1996. A stimulatory role of cyclic adenosine 3′,5′-monophosphate in follicle-stimulating hormone-activated mitogen-activated protein kinase signaling pathway in rat ovarian granulosa cells. Endocrinology 137:967-974.
19. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL. 1998. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474-477.
20. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, VanDyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskps JM. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623-18632.
21. Gordon GB, Helzlouer KJ, Comstock GW. 1991. Serum levels of DHEA and its sulfate and the risk of developing bladder cancer. Cancer Res 51:1366-1369.
22. Graves LM, Bornfeldt KE, Raines EW, Potts BC, Macdonald SG, Ross R, Krebs EG. 1993. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci USA 90:10300-10304.
23. Gyles SL, Burns CJ, Whitehouse BJ, Sugden D, Marsh PJ, Persaud SJ, Jones PM. 2001. ERK regulate cyclic AMP-induced steroid synthesis through transcription of the steroidogenic acute regulatory (StAR) gene. J Biol Chem 276:34888-34895.
24. Hammer GD, Krylova I, Zhang Y, Darimont BD, Simpson K, Weigel NL, Ingraham HA. 1999. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: Integration of hormone signaling in reproduction and stress. Mol Cell 3:521-526.
25. Ikeda Y, Swain A, Weber TJ, Hentges KE, Zanaria E, Lalli E, Tamai KT, Sassone-Corsi P, Lovell-Badge R, Camerino G, Parker KL. 1996. Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: Potential links in endocrine development. Mol Endocrinol 10:1261-1272.
26. Kau MM, Chen JJ, Wang SW, Cho WL, Wang PS. 1999. Age-related impairment of aldosterone secretion in zona glomerulosa cells of ovariectomized rats. J Invest Med 47:425-432.
27. Lewis TS, Shapiro PS, Ahn NG. 1998. Signal transduction through MAP kinase cascades. Adv Cancer Res 74:49-139.
28. Lo MJ, Kau MM, Chen YH, Tsai SC, Chiao YC, Chen JJ, Liaw C, Lu CC, Lee BP, Chen SC, Fang VS, Ho LT, Wang PS. 1998. Acute effects of thyroid hormones on the production of adrenal cAMP and corticosterone in male rats. Am J Physiol 274:E238-E245.
29. Lo MJ, Kau MM, Cho WL, Wang PS. 2000. Aging effects on the secretion of corticosterone in male rats. J Invest Med 48:335-342.
30. Lotfi CF, Lepique AP, Forti FL, Schwindt TT, Eichler CB, Santos MO, Rebustini IT, Hajj GN, Juliano L, Armelin HA. 2000. Proliferative signaling initiated in ACTH receptors. Braz J Med Biol Res 33:1133-1140.
31. Morohashi KI, Omura T. 1996. Ad4BP/SF-1 a transcription factor essential for the transcription of steroidogenic cytochrome P450 genes and for the establishment of the reproductive function. FASEB J 10:1569-1577.
32. Orly J, Stocco DM. 1999. The role of the steroidogenic acute regulatory (StAR) protein in female reproductive tissues. Horm Metab Res 31:389-398.
33. Orly J, Rei Z, Greenberg NM, Richards JS. 1994. Tyrosine kinase inhibitor AG18 arrests FSH-induced granulosa cell differentiation: Use of semi-quantitative RT-PCR assay for multiple mRNA. Endocrinology 134:2336-2346.
34. Penhoat A, Jaillard C, Saez JM. 1994. Regulation of bovine adrenal cell corticotropin receptor mRNA levels by corticotropin (ACTH) and angiotensin-II (A-II). Mol Cell Endocrinol 103:R7-R10.
35. Purdy SJ, Whitehouse BJ, Abayasekara DR. 1991. Stimulation of steroidogenesis by forskolin in rat adrenal zona glomerulosa preparations. J Endocrinol 129:391-397.
36. Ronen-Fuhrmann T, Timberg R, King SR, Hales KH, Hales DB, Stocco DM, Orly J. 1998. Spatio-temporal expression patterns of steroidogenic acute regulatory protein (StAR) during follicular development in the rat ovary. Endocrinology 139:303-315.
37. Schimmer BP. 1980. Cyclic nucleotides in hormonal regulation of adrenocortical function. Adv Cyclic Nucleotide Res 13:181-214.
38. Schwartz A, Whitcomb J, Fairman D, Hastings L, Lewbart M. 1989. Inhibition of tumorigenesis by DHEA and structural analogues. In: Lardy H, Stratman F, editors. Hormones, thermogenesis, and obesity. New York: Elsevier, pp 441-452.
39. Seger R, Krebs EG. 1995. The MAPK signaling cascade. FASEB J 9:726-735.
40. Simpson ER, Waterman MR. 1988. Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Annu Rev Physiol 50:427-440.
41. Steel RGD, Torrie JH. 1960. Principles and procedures of statistics. New York: McGraw Hill.
42. Stocco DM, Clark BJ. 1996. Role of the steroidogenic acute regulatory protein (StAR) in steroidogenesis. Biochem Pharmacol 51:197-205.
43. Svee F, Porter JR. 1998. The actions of exogenous dehydroepiandrosterone in experimental animals and humans. Proc Soc Exp Biol Med 218:174-191.
44. Tajima K, Dantes A, Yao Z, Sorokina K, Kotsuji F, Seger R, Amsterdam A. 2003. Down-regulation of steroidogenic response to gonadotropins in human and rat preovulatory granulose cells involves mitogen-activated protein kinase activation and modulation of DAX-1 and steroidogenic factor-1. J Clin Endocrinol Metab 88:2288-2299.
45. Tamai KT, Monaco L, Alastalo TP, Lalli E, Parvinen M, Sassone-Corsi P. 1996. Hormonal and developmental regulation of DAX-1 expression in sertolli cells. Mol Endocrinol 10:1561-1569.
46. Vossler MR, Yao H, York RD, Pan MG, Rim CS, Stork PJS. 1997. cAMP activates MAP kinase and Elk-1 through a B-Raf and Rap 1-dependent pathway. Cell 89:73-82.
47. Wellman M, Shane-McWhorter L, Orlando PL, Jennings JP. 1999. The role of dehydroepiandrosterone in diabetes mellitus. Pharmacotherapy 19:582-591.
48. Wong M, Krolczyk AJ, Schimmer BP. 1992. The causal relationship between mutations in cAMP-dependent protein kinase and the loss of adrenocorticotropin- regulated adrenocortical functions. Mol Endocrinol 6: 1614-1624.
49. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW. 1993. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262:1065-1069.